Rare diseases
Investigational molecules
Locations
101 Redwood Shores Parkway, 94065-1176, United States
Corcept Therapeutics Inc. is involved in clinical research on endogenous Cushing syndrome, with attention to the long-term management of the signs and symptoms associated with excess cortisol activity.
The sponsor’s work in this area centers on endocrine disease and the clinical management of chronic hypercortisolism.
Corcept Therapeutics Inc. runs clinical trials in conditions such as Fallopian tube cancer, Ovarian cancer, Peritoneal neoplasm, Amyotrophic lateral sclerosis, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Study on the Safety and Effectiveness of Dazucorilant for Patients with Amyotrophic Lateral Sclerosis (ALS)
BelgiumStudy of Relacorilant, Nab-Paclitaxel, and Bevacizumab for Patients with Advanced Ovarian, Peritoneal, or Fallopian Tube Cancer
BelgiumStudy on the Long-Term Safety of Relacorilant for Patients with Cushing Syndrome
AustriaStudy of Relacorilant and Nab-Paclitaxel for Patients with Advanced, Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer
BelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
